47045-NGA-H-NASCP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nigeria, HIV, National AIDS, Viral Hepatitis and STIs Control Programme Goals: To end HIV epidemics by the year 2030; End vertical transmission of HIV. Objectives: To achieve 95-95-95 target by 2025; Scale-up PMTCT services (includign reaching womne who cannot access services from health facilities). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme National AIDS, Viral Hepatitis and STIs Control Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Jean-Thomas Nouboussi Fund Portfolio Manager +41 58 791 1700 jean.nouboussi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nigeria HIV Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Retention support for pregnant and breastfeeding women (facility and community) HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings HIV -> Prevention program stewardship -> Prevention program stewardship HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Drug resistance HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory Information systems RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: National laboratory governance and management structures RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination RSSH -> RSSH: Health products management systems -> Supply chain information systems RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria 2739637.88 12223933.17 8997918.48 12822293.09 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 12938287.00 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme -12822293.09 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 6.15 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 1485035.71 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 1000000.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 422770.24 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 804574.02 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 2000692.46 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 299029.19 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 296857.80 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 12071.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme -6617250.43 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 8187245.08 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 231150.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 10.00 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 500000.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 6386532.29 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 691623.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 12071.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 117374.40 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 2128811.76 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme -365858.79 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 500000.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 193037.15 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 117374.40 Global Fund disbursement to NGA-H-NASCPP01 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme -193037.15 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 273381.20 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 368997.40 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme -1628811.76 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 7185283.62 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme -368997.40 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 2725912.61 Global Fund disbursement to NGA-H-NASCPP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 742487.70 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 274348.00 Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 866.35 Funds returned to the Global Fund from NGA-H-NASCPP01 (Pooled Procurement Mechanism). National AIDS, Viral Hepatitis and STIs Control Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -866.35 Global Fund commitment to NGA-H-NASCPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National AIDS, Viral Hepatitis and STIs Control Programme 1739637.89 Expenditure reported by National AIDS, Viral Hepatitis and STIs Control Programme for NGA-H-NASCPP01, Jan 2024 to Dec 2024. National AIDS, Viral Hepatitis and STIs Control Programme 7824691.00 Expenditure reported by National AIDS, Viral Hepatitis and STIs Control Programme for NGA-H-NASCPP01, Jan 2025 to Dec 2025. National AIDS, Viral Hepatitis and STIs Control Programme An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR1535-NGA-C. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. 2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation. 3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of US$ 51,540,742 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.3(1)(a) and 6.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: a. progressively increase government expenditure on health to meet national universal health coverage goals; and/or b. increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in the co-financing commitment letter to be signed by the Government of Nigeria and submitted in form and substance satisfactory to the Global Fund, by 30 June 2024: (a) fulfil a total minimum co-financing commitment; (b) fulfil the programmatic commitments as stipulated in the co-financing commitment letter; and (c) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV and RSSH for the upcoming year; and ii. the total expenditure for HIV and RSSH in the previous fiscal year. (3) The Grantee should also work with the Country Coordinating Mechanism to establish co-financing agreements with States that are Sub-recipients in the Grant. To that end, with respect to each relevant State, the Grantee must provide the Global Fund with (i) the approved state annual budget for HIV and RSSH for the upcoming year and (ii) total state government expenditure on HIV and RSSH in the previous year. 4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement. 5 - (1) Grant Funds may be used to pay for services performed by a fiscal agent retained by the Global Fund (the “Fiscal Agent”) and the Global Fund may disburse such Grant Funds directly to the Fiscal Agent; (2) The Principal Recipient consents to the terms of reference of the Fiscal Agent and agrees that such terms of reference may be amended from time to time at the Global Fund’s discretion; (3) The Principal Recipient shall cooperate fully with the Fiscal Agent to allow the Fiscal Agent to perform its services, including, but not limited to, by (a) providing all information requested by the Fiscal Agent or the Global Fund; (b) taking all necessary actions prior to collection of Personal Data and at all times thereafter to ensure that the processing of Personal Data by the Fiscal Agent does not violate any applicable law or regulation; and (c) implementing any recommendations made by the Fiscal Agent; and (4) The appointment of the Fiscal Agent shall not, nor shall it be construed to, discharge the Grantee nor the Principal Recipient of their respective obligations under the Grant Agreement, which shall remain in full force and effect. The Fiscal Agent shall not have authority to act as the Global Fund’s agent, unless provided otherwise in writing by the Global Fund. Accordingly, the Global Fund reserves the right to classify any expenditure of Grant Funds as non-compliant, notwithstanding its verification or endorsement by the Fiscal Agent. 6 - (1) Grant Funds may be used to pay for the services of an external auditor or for a Supreme Audit Institution approved by the Global Fund retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; and (2) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund. Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 11390; Denominator: 96517; Percentage: 11.8%. Numerator: 11052; Denominator: 26145; Percentage: 42.27%. Numerator: 11052; Denominator: 26145; Percentage: 42.27%. Numerator: 338; Denominator: 26145; Percentage: 1.29%. Numerator: 338; Denominator: 26145; Percentage: 1.29%. Numerator: 17414; Denominator: 87070; Percentage: 20%. Numerator: 34828; Denominator: 87070; Percentage: 40%. Numerator: 17528; Denominator: 87070; Percentage: 20.13%. Numerator: 17414; Denominator: 87070; Percentage: 20%. Numerator: 6992; Denominator: 87070; Percentage: 8.03%. Numerator: 23248. Numerator: 313. Numerator: 56903.8; Denominator: 81291; Percentage: 70%. Numerator: 26449; Denominator: 81291; Percentage: 32.54%. Numerator: 28451.85; Denominator: 81291; Percentage: 35%. Numerator: 28451.85; Denominator: 81291; Percentage: 35%. Numerator: 14604; Denominator: 81291; Percentage: 17.97%. Numerator: 21865. Numerator: 309. Numerator: 35982.2; Denominator: 75752; Percentage: 47.5%. Numerator: 35982.2; Denominator: 75752; Percentage: 47.5%. Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 2068967; Denominator: 7985986; Percentage: 25.91%. Numerator: 2061691; Denominator: 7707635; Percentage: 26.75%. Numerator: 2061691; Denominator: 7707635; Percentage: 26.75%. Numerator: 7276; Denominator: 7707635; Percentage: 0.09%. Numerator: 7276; Denominator: 7707635; Percentage: 0.09%. Numerator: 1976156; Denominator: 8697518; Percentage: 22.72%. Numerator: 3952312; Denominator: 8697518; Percentage: 45.4%. Numerator: 5202964; Denominator: 8697518; Percentage: 59.82%. Numerator: 1976156; Denominator: 8697518; Percentage: 22.72%. Numerator: 3553697; Denominator: 8697518; Percentage: 40.86%. Numerator: 5174909. Numerator: 28244. Numerator: 6672084.8; Denominator: 8896113; Percentage: 75%. Numerator: 6393292; Denominator: 8896113; Percentage: 71.87%. Numerator: 3336042.38; Denominator: 8896113; Percentage: 37.5%. Numerator: 3336042.38; Denominator: 8896113; Percentage: 37.5%. Numerator: 3209861; Denominator: 8896113; Percentage: 36.08%. Numerator: 6384892. Numerator: 8400. Numerator: 4322843.9; Denominator: 9100724; Percentage: 47.5%. Numerator: 4322843.9; Denominator: 9100724; Percentage: 47.5%. Module: TB/HIV. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 242339; Denominator: 1911502; Percentage: 12.68%. Numerator: 1708370; Denominator: 1860826; Percentage: 91.81%. Numerator: 1708370; Denominator: 1860826; Percentage: 91.81%. Numerator: 44218; Denominator: 44218; Percentage: 100%. Numerator: 44218; Denominator: 44218; Percentage: 100%. Numerator: 1385; Denominator: 3932; Percentage: 35.22%. Numerator: 1385; Denominator: 3932; Percentage: 35.22%. Numerator: 638278; Denominator: 689371; Percentage: 92.59%. Numerator: 638278; Denominator: 689371; Percentage: 92.59%. Numerator: 1131747; Denominator: 1222131; Percentage: 92.6%. Numerator: 1131747; Denominator: 1222131; Percentage: 92.6%. Numerator: 6458; Denominator: 6458; Percentage: 100%. Numerator: 6458; Denominator: 6458; Percentage: 100%. Percentage: 15%. Numerator: 145242; Denominator: 1629359; Percentage: 8.91%. Percentage: 15%. Percentage: 15%. Numerator: 101464; Denominator: 1629359; Percentage: 6.23%. Numerator: 141926. Numerator: 118. Numerator: 2803. Numerator: 35298. Numerator: 21200. Numerator: 0. Percentage: 17%. Numerator: 215759; Denominator: 1738406; Percentage: 12.41%. Percentage: 17%. Percentage: 17%. Numerator: 181024; Denominator: 1738406; Percentage: 10.41%. Numerator: 211166. Numerator: 120. Numerator: 2993. Numerator: 137173. Numerator: 87556. Numerator: 0. Percentage: 20%. Percentage: 20%. Module: TB/HIV. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1554089.33; Denominator: 1911502. Numerator: 131896; Denominator: 131896. Numerator: 99858; Denominator: 82943. Numerator: 108214; Denominator: 117409. Numerator: 55477; Denominator: 62672. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 50676; Denominator: 159923. Numerator: 25480; Denominator: 50676. Numerator: 25480; Denominator: 50676. Numerator: 25196; Denominator: 50676. Numerator: 25196; Denominator: 50676. Numerator: 77834; Denominator: 131922. Numerator: 49820; Denominator: 131922. Numerator: 64255; Denominator: 131922. Numerator: 77834; Denominator: 131922. Numerator: 49820; Denominator: 131922. Numerator: 25016; Denominator: 49820. Numerator: 24804; Denominator: 49820. Numerator: 90836; Denominator: 121114. Numerator: 46519; Denominator: 121114. Numerator: 84335; Denominator: 121114. Numerator: 90836; Denominator: 121114. Numerator: 46519; Denominator: 121114. Numerator: 23166; Denominator: 46519. Numerator: 23353; Denominator: 46519. Numerator: 97967; Denominator: 110629. Numerator: 105098; Denominator: 110629. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1706470; Denominator: 1911502. Numerator: 658206; Denominator: 658206. Numerator: 658206; Denominator: 658206. Numerator: 1166041; Denominator: 1166041. Numerator: 1166041; Denominator: 1166041. Numerator: 1845603; Denominator: 1942740. Numerator: 1060122; Denominator: 1629356. Numerator: 1845603; Denominator: 1942740. Numerator: 1845603; Denominator: 1942740. Numerator: 1060122; Denominator: 1629356. Numerator: 1027006; Denominator: 1060122. Numerator: 33; Denominator: 1060122. Numerator: 1824237; Denominator: 1920249. Numerator: 1824237; Denominator: 1920249. Numerator: 1294518; Denominator: 1920249. Numerator: 1824237; Denominator: 1920249. Numerator: 1294518; Denominator: 1920249. Numerator: 1254036; Denominator: 1294518. Numerator: 40482; Denominator: 1294518. Numerator: 1803108; Denominator: 1898008. Numerator: 1803108; Denominator: 1898008. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1911502; Denominator: 1984170. Numerator: 1222131; Denominator: 1244707. Numerator: 1222131; Denominator: 1244707. Numerator: 689371; Denominator: 739463. Numerator: 689371; Denominator: 739463. Numerator: 1942740; Denominator: 1942740. Numerator: 1629356; Denominator: 1942740. Numerator: 1942740; Denominator: 1942740. Numerator: 1942740; Denominator: 1942740. Numerator: 1629356; Denominator: 1942740. Numerator: 1060629; Denominator: 1629359. Numerator: 568730; Denominator: 1629359. Numerator: 1920249; Denominator: 1920249. Numerator: 1920249; Denominator: 1920249. Numerator: 1738406; Denominator: 1920249. Numerator: 1920249; Denominator: 1920249. Numerator: 1738406; Denominator: 1920249. Numerator: 1136949; Denominator: 1738406. Numerator: 599324; Denominator: 1738406. Numerator: 1898008; Denominator: 1898008. Numerator: 1898008; Denominator: 1898008. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 32381; Denominator: 96517. Numerator: 47889; Denominator: 87070. Numerator: 26466; Denominator: 87070. Numerator: 23944.5; Denominator: 87070. Numerator: 23944.5; Denominator: 87070. Numerator: 15081; Denominator: 87070. Numerator: 60968; Denominator: 81291. Numerator: 27728; Denominator: 81291. Numerator: 30484; Denominator: 81291. Numerator: 30484; Denominator: 81291. Numerator: 13320; Denominator: 81291. Numerator: 35982; Denominator: 75752. Numerator: 35982; Denominator: 75752.